1. Home
  2. MOVE vs SABS Comparison

MOVE vs SABS Comparison

Compare MOVE & SABS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MOVE
  • SABS
  • Stock Information
  • Founded
  • MOVE 2018
  • SABS 2014
  • Country
  • MOVE United States
  • SABS United States
  • Employees
  • MOVE N/A
  • SABS N/A
  • Industry
  • MOVE Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • SABS Biotechnology: Pharmaceutical Preparations
  • Sector
  • MOVE Health Care
  • SABS Health Care
  • Exchange
  • MOVE Nasdaq
  • SABS Nasdaq
  • Market Cap
  • MOVE 25.9M
  • SABS 23.9M
  • IPO Year
  • MOVE 2021
  • SABS N/A
  • Fundamental
  • Price
  • MOVE $3.26
  • SABS $3.10
  • Analyst Decision
  • MOVE Buy
  • SABS Strong Buy
  • Analyst Count
  • MOVE 1
  • SABS 5
  • Target Price
  • MOVE $30.00
  • SABS $12.40
  • AVG Volume (30 Days)
  • MOVE 62.0K
  • SABS 78.1K
  • Earning Date
  • MOVE 11-14-2024
  • SABS 11-06-2024
  • Dividend Yield
  • MOVE N/A
  • SABS N/A
  • EPS Growth
  • MOVE N/A
  • SABS N/A
  • EPS
  • MOVE N/A
  • SABS N/A
  • Revenue
  • MOVE $902,000.00
  • SABS $1,512,723.00
  • Revenue This Year
  • MOVE N/A
  • SABS N/A
  • Revenue Next Year
  • MOVE $443.49
  • SABS N/A
  • P/E Ratio
  • MOVE N/A
  • SABS N/A
  • Revenue Growth
  • MOVE N/A
  • SABS N/A
  • 52 Week Low
  • MOVE $3.01
  • SABS $2.16
  • 52 Week High
  • MOVE $14.70
  • SABS $9.72
  • Technical
  • Relative Strength Index (RSI)
  • MOVE 33.01
  • SABS 48.28
  • Support Level
  • MOVE $3.76
  • SABS $3.17
  • Resistance Level
  • MOVE $4.28
  • SABS $3.74
  • Average True Range (ATR)
  • MOVE 0.48
  • SABS 0.48
  • MACD
  • MOVE -0.03
  • SABS -0.04
  • Stochastic Oscillator
  • MOVE 15.47
  • SABS 17.53

About MOVE Movano Inc.

Movano Inc is developing a platform to deliver purpose-driven healthcare solutions to bring medical-grade, high-quality data to the forefront of consumer health devices. its initial commercial product in development is the Evie Ring, a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one's health, which includes resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

Share on Social Networks: